https://www.vagusresearch.com/studies/handforth-1998-therapy-partial yearly 0.4 https://www.vagusresearch.com/studies/tassorelli-2018-acute-therapy yearly 0.4 https://www.vagusresearch.com/studies/kim-2022-safety yearly 0.4 https://www.vagusresearch.com/studies/jiao-2020-concha-insomnia yearly 0.4 https://www.vagusresearch.com/studies/dawson-2021-paired-rehabilitation yearly 0.4 https://www.vagusresearch.com/studies/burger-2019-reduces-spontaneous yearly 0.4 https://www.vagusresearch.com/studies/englot-2011-epilepsy-efficacy yearly 0.4 https://www.vagusresearch.com/studies/kutlu-2020-impact-pain yearly 0.4 https://www.vagusresearch.com/studies/hein-2013-electrical-depressed yearly 0.4 https://www.vagusresearch.com/studies/tan-2023-efficacy-safety yearly 0.4 https://www.vagusresearch.com/studies/liu-2024-post-stroke yearly 0.4 https://www.vagusresearch.com/studies/rush-2005-treatment-resistant yearly 0.4 https://www.vagusresearch.com/studies/yakunina-2017-optimization-functional yearly 0.4 https://www.vagusresearch.com/studies/bretherton-2019-individuals-aged yearly 0.4 https://www.vagusresearch.com/studies/de-oliveira-2025-insomnia yearly 0.4 https://www.vagusresearch.com/studies/wu-2022-could-improve yearly 0.4 https://www.vagusresearch.com/studies/zhang-2024-chronic-insomnia yearly 0.4 https://www.vagusresearch.com/studies/schiweck-2024-consistent-evidence yearly 0.4 https://www.vagusresearch.com/studies/lombo-2025-autoimmune-conditions yearly 0.4 https://www.vagusresearch.com/studies/okdahl-2024-has-anti yearly 0.4 https://www.vagusresearch.com/studies/ben-menachem-1994-treatment-partial yearly 0.4 https://www.vagusresearch.com/studies/yang-2023-treatment-drug yearly 0.4 https://www.vagusresearch.com/studies/gurel-2020-reduces-sympathetic yearly 0.4 https://www.vagusresearch.com/studies/wittbrodt-2021-alters-brain yearly 0.4 https://www.vagusresearch.com/studies/bremner-2020-blocks-stress yearly 0.4 https://www.vagusresearch.com/studies/silberstein-2016-acute-treatment yearly 0.4 https://www.vagusresearch.com/studies/goadsby-2018-acute-treatment yearly 0.4 https://www.vagusresearch.com/studies/silberstein-2016-chronic-migraine yearly 0.4 https://www.vagusresearch.com/studies/diener-2019-nvns-preventive yearly 0.4 https://www.vagusresearch.com/studies/najib-2022-prevention-migraine yearly 0.4 https://www.vagusresearch.com/studies/kimberley-2018-paired-upper yearly 0.4 https://www.vagusresearch.com/studies/dawson-2023-paired-rehabilitation yearly 0.4 https://www.vagusresearch.com/studies/gold-2016-treatment-heart yearly 0.4 https://www.vagusresearch.com/studies/zannad-2015-chronic-treatment yearly 0.4 https://www.vagusresearch.com/studies/tyler-2017-paired-tones yearly 0.4 https://www.vagusresearch.com/studies/jacobs-2015-boosts-associative yearly 0.4 https://www.vagusresearch.com/studies/wang-2022-efficacy-safety yearly 0.4 https://www.vagusresearch.com/studies/zhou-2022-delayed-neurocognitive yearly 0.4 https://www.vagusresearch.com/studies/conway-2025-treatment-resistant yearly 0.4 https://www.vagusresearch.com/studies/liu-2024-efficacy-safety yearly 0.4 https://www.vagusresearch.com/studies/xiong-2025-postpartum-contraction yearly 0.4 https://www.vagusresearch.com/studies/glue-2024-extended-release yearly 0.4 https://www.vagusresearch.com/studies/morkl-2025-multi-species yearly 0.4 https://www.vagusresearch.com/studies/rush-2025-daily-function yearly 0.4 https://www.vagusresearch.com/studies/li-2025-treatment-erythematotelangiectatic yearly 0.4 https://www.vagusresearch.com/studies/yldz-kzkn-2025-individuals-primary yearly 0.4 https://www.vagusresearch.com/studies/badran-2022-supervised-home yearly 0.4 https://www.vagusresearch.com/studies/li-2022-assessor-blinded yearly 0.4 https://www.vagusresearch.com/studies/qi-2025-baseline-functional yearly 0.4 https://www.vagusresearch.com/studies/klinkenberg-2013-behavioural-cognitive yearly 0.4 https://www.vagusresearch.com/studies/zhang-2025-hemodialysis yearly 0.4 https://www.vagusresearch.com/studies/zhang-2020-adjunctive-treatment yearly 0.4 https://www.vagusresearch.com/studies/bottomley-2019-therapy-treatment yearly 0.4 https://www.vagusresearch.com/studies/zhou-2023-transauricular-disorders yearly 0.4 https://www.vagusresearch.com/studies/jain-2021-seizure-outcomes yearly 0.4 https://www.vagusresearch.com/studies/hajtovic-2022-role-genetic yearly 0.4 https://www.vagusresearch.com/studies/pan-2024-improves-working yearly 0.4 https://www.vagusresearch.com/studies/haneef-2023-neurostimulation-generalized yearly 0.4 https://www.vagusresearch.com/studies/lim-2022-treatment-drug yearly 0.4 https://www.vagusresearch.com/studies/moro-2025-can-considered yearly 0.4 https://www.vagusresearch.com/studies/suresh-2024-add-deep yearly 0.4 https://www.vagusresearch.com/studies/wu-2020-treatment-drug yearly 0.4 https://www.vagusresearch.com/studies/melese-2024-seizure-control yearly 0.4 https://www.vagusresearch.com/studies/ochoa-2021-treatment-super yearly 0.4 https://www.vagusresearch.com/studies/kong-2024-cognitive-function yearly 0.4 https://www.vagusresearch.com/studies/steidel-2021-influences-gastric yearly 0.4 https://www.vagusresearch.com/studies/mao-2022-short-long yearly 0.4 https://www.vagusresearch.com/studies/touma-2022-neurostimulation-people yearly 0.4 https://www.vagusresearch.com/studies/zhang-2024-epilepsy yearly 0.4 https://www.vagusresearch.com/studies/lampros-2021-epilepsy-literature yearly 0.4 https://www.vagusresearch.com/studies/yamamoto-2022-application yearly 0.4 https://www.vagusresearch.com/studies/zhang-2024-improves-anxiety yearly 0.4 https://www.vagusresearch.com/studies/jerman-2025-evaluating-pemf yearly 0.4 https://www.vagusresearch.com/studies/zhang-2023-insomnia-people yearly 0.4 https://www.vagusresearch.com/studies/ferreira-2024-modulates-masseter yearly 0.4 https://www.vagusresearch.com/studies/lee-2025-functional-dyspepsia yearly 0.4 https://www.vagusresearch.com/studies/li-2022-comparative-effectiveness yearly 0.4 https://www.vagusresearch.com/studies/srinivasan-2024-efficacy-anxiety yearly 0.4 https://www.vagusresearch.com/studies/pan-2025-treat-narcolepsy yearly 0.4 https://www.vagusresearch.com/studies/prott-2025-treatment-myoarthropathic yearly 0.4 https://www.vagusresearch.com/studies/zhang-2021-migraine-fmri yearly 0.4 https://www.vagusresearch.com/studies/costa-2024-chronic-pain yearly 0.4 https://www.vagusresearch.com/studies/song-2023-migraine-trials yearly 0.4 https://www.vagusresearch.com/studies/vanderpluym-2021-acute-treatments yearly 0.4 https://www.vagusresearch.com/studies/duff-2024-efficacy-treatment yearly 0.4 https://www.vagusresearch.com/studies/lai-2020-migraine-cluster yearly 0.4 https://www.vagusresearch.com/studies/beh-2019-acute-vestibular yearly 0.4 https://www.vagusresearch.com/studies/grazzi-2016-nvns-mini yearly 0.4 https://www.vagusresearch.com/studies/likar-2024-efficacy-treatment yearly 0.4 https://www.vagusresearch.com/studies/huang-2023-modulation-repeated yearly 0.4 https://www.vagusresearch.com/studies/sacca-2023-evaluation-modulation yearly 0.4 https://www.vagusresearch.com/studies/farahani-2026-adding-vestibular yearly 0.4 https://www.vagusresearch.com/studies/mondal-2023-symptoms-molecular yearly 0.4 https://www.vagusresearch.com/studies/pellow-2025-effectiveness-heart yearly 0.4 https://www.vagusresearch.com/studies/martelletti-2018-consistent-nvns yearly 0.4 https://www.vagusresearch.com/studies/ma-2025-epilepsy-comorbid yearly 0.4 https://www.vagusresearch.com/studies/may-2023-european-academy yearly 0.4 https://www.vagusresearch.com/studies/de-coo-2019-differential-efficacy yearly 0.4 https://www.vagusresearch.com/studies/fernandez-hernando-2023-neuromodulation-management-1470 yearly 0.4 https://www.vagusresearch.com/studies/marin-2018-treatment-cluster yearly 0.4 https://www.vagusresearch.com/studies/simmonds-2023-open-label yearly 0.4 https://www.vagusresearch.com/studies/mwamburi-2017-cost-effectiveness yearly 0.4 https://www.vagusresearch.com/studies/van-tilborg-2025-implanted-stimulator yearly 0.4 https://www.vagusresearch.com/studies/stavrakis-2024-postural-tachycardia yearly 0.4 https://www.vagusresearch.com/studies/tseng-2026-network-efficacy yearly 0.4 https://www.vagusresearch.com/studies/sun-2025-efficacy-heart yearly 0.4 https://www.vagusresearch.com/studies/kalagara-2025-complications-implanted yearly 0.4 https://www.vagusresearch.com/studies/stavrakis-2022-neuromodulation-inflammation yearly 0.4 https://www.vagusresearch.com/studies/ahmed-2024-pharmacologic-autonomic yearly 0.4 https://www.vagusresearch.com/studies/nagai-2024-blood-pressure yearly 0.4 https://www.vagusresearch.com/studies/lee-2016-chronic-cyclic yearly 0.4 https://www.vagusresearch.com/studies/stavrakis-2020-treat-electrical yearly 0.4 https://www.vagusresearch.com/studies/umana-mejia-2025-efficacy-suppress yearly 0.4 https://www.vagusresearch.com/studies/elamin-2023-its-cardioprotective yearly 0.4 https://www.vagusresearch.com/studies/stavrakis-2017-low-level yearly 0.4 https://www.vagusresearch.com/studies/budhiraja-2024-potential-treating yearly 0.4 https://www.vagusresearch.com/studies/yuan-2015-continuous-affects yearly 0.4 https://www.vagusresearch.com/studies/dai-2017-extrinsic-cardiac yearly 0.4 https://www.vagusresearch.com/studies/kimberley-2025-long-term yearly 0.4 https://www.vagusresearch.com/studies/wang-2023-post-stroke yearly 0.4 https://www.vagusresearch.com/studies/wang-2024-efficacy-observation yearly 0.4 https://www.vagusresearch.com/studies/wen-2025-inhibits-pyroptosis yearly 0.4 https://www.vagusresearch.com/studies/gao-2023-paired-rehabilitation yearly 0.4 https://www.vagusresearch.com/studies/ananda-2023-efficacy-safety yearly 0.4 https://www.vagusresearch.com/studies/zhou-2025-adjuvant-post yearly 0.4 https://www.vagusresearch.com/studies/ahmed-2023-brain-techniques yearly 0.4 https://www.vagusresearch.com/studies/xie-2021-upper-limb yearly 0.4 https://www.vagusresearch.com/studies/wang-2023-application-rehabilitation yearly 0.4 https://www.vagusresearch.com/studies/ramos-castaneda-2022-efficacy-safety yearly 0.4 https://www.vagusresearch.com/studies/dawson-2016-safety-feasibility yearly 0.4 https://www.vagusresearch.com/studies/zhao-2022-paired-rehabilitation yearly 0.4 https://www.vagusresearch.com/studies/abdullahi-2023-safety-upper yearly 0.4 https://www.vagusresearch.com/studies/wang-2024-task-oriented yearly 0.4 https://www.vagusresearch.com/studies/khan-2025-implantable-stimulator yearly 0.4 https://www.vagusresearch.com/studies/elsehrawy-2025-pain-modulator yearly 0.4 https://www.vagusresearch.com/studies/eid-2024-chronic-low yearly 0.4 https://www.vagusresearch.com/studies/li-2025-modulates-functional yearly 0.4 https://www.vagusresearch.com/studies/zhang-2025-effectiveness-alleviating yearly 0.4 https://www.vagusresearch.com/studies/camargo-2025-resting-state yearly 0.4 https://www.vagusresearch.com/studies/yuan-2025-international-headache yearly 0.4 https://www.vagusresearch.com/studies/aranow-2021-reduces-pain yearly 0.4 https://www.vagusresearch.com/studies/yin-2025-impact-postoperative yearly 0.4 https://www.vagusresearch.com/studies/pikov-2023-sacral-inflammatory yearly 0.4 https://www.vagusresearch.com/studies/croft-2025-efficacy-applications yearly 0.4 https://www.vagusresearch.com/studies/chan-2025-assessing-therapeutic yearly 0.4 https://www.vagusresearch.com/studies/veldman-2025-efficacy-gastrointestinal yearly 0.4 https://www.vagusresearch.com/studies/yan-2023-relives-irritable yearly 0.4 https://www.vagusresearch.com/studies/saleh-2026-chronic-constipation yearly 0.4 https://www.vagusresearch.com/studies/mei-1990-intestinal-sensitivity yearly 0.4 https://www.vagusresearch.com/studies/kornum-2024-treating-gastrointestinal yearly 0.4 https://www.vagusresearch.com/studies/cimpianu-2017-psychiatry-available yearly 0.4 https://www.vagusresearch.com/studies/schwartz-2022-understanding-mental yearly 0.4 https://www.vagusresearch.com/studies/streeter-2012-yoga-autonomic yearly 0.4 https://www.vagusresearch.com/studies/gazi-2021-inhibits-reciprocal yearly 0.4 https://www.vagusresearch.com/studies/yeom-2025-improves-sleep yearly 0.4 https://www.vagusresearch.com/studies/krone-2023-brain-techniques yearly 0.4 https://www.vagusresearch.com/studies/yang-2024-efficacy-transauricular yearly 0.4 https://www.vagusresearch.com/studies/stegeman-2021-tinnitus-treatment yearly 0.4 https://www.vagusresearch.com/studies/wu-2023-meniere-disease yearly 0.4 https://www.vagusresearch.com/studies/fernandez-hernando-2023-neuromodulation-management-b439 yearly 0.4 https://www.vagusresearch.com/studies/taha-2024-inflammatory-markers yearly 0.4 https://www.vagusresearch.com/studies/tornero-2022-covid-results yearly 0.4 https://www.vagusresearch.com/studies/rangon-2021-neuromodulation-mass yearly 0.4 https://www.vagusresearch.com/studies/seitz-2023-evaluate-safety yearly 0.4 https://www.vagusresearch.com/studies/uehara-2022-inflammatory-markers yearly 0.4 https://www.vagusresearch.com/studies/correa-2022-improves-inflammation yearly 0.4 https://www.vagusresearch.com/studies/hua-2024-weight-obesity yearly 0.4 https://www.vagusresearch.com/studies/shen-2025-metabolism yearly 0.4 https://www.vagusresearch.com/studies/qiu-2024-neuromodulation-treatment yearly 0.4 https://www.vagusresearch.com/studies/kufaishi-2025-possible-glycemic yearly 0.4 https://www.vagusresearch.com/studies/aniwattanapong-2022-attention-working yearly 0.4 https://www.vagusresearch.com/studies/mertens-2020-does-not yearly 0.4 https://www.vagusresearch.com/studies/zhang-2023-improves-gait yearly 0.4 https://www.vagusresearch.com/studies/eissazade-2025-parkinson-disease yearly 0.4 https://www.vagusresearch.com/studies/shan-2024-parkinson-disease yearly 0.4 https://www.vagusresearch.com/studies/matsuoka-2025-healthy-individuals yearly 0.4 https://www.vagusresearch.com/studies/abdelnaby-2021-ultrasonography-parkinson yearly 0.4 https://www.vagusresearch.com/studies/proietti-2025-movement-disorders yearly 0.4 https://www.vagusresearch.com/studies/wang-2024-advances-efficiency yearly 0.4 https://www.vagusresearch.com/studies/tesser-2026-mediated-neuroimmune yearly 0.4 https://www.vagusresearch.com/studies/baker-2023-double-blind yearly 0.4 https://www.vagusresearch.com/studies/peterson-2024-safety-feasibility yearly 0.4 https://www.vagusresearch.com/studies/redgrave-2018-safety-tolerability yearly 0.4 https://www.vagusresearch.com/studies/sigrist-2023-pediatric-treatment yearly 0.4 https://www.vagusresearch.com/studies/pichardo-rojas-2025-optimizing-super yearly 0.4 https://www.vagusresearch.com/studies/boon-2018-neurostimulation-drug yearly 0.4 https://www.vagusresearch.com/studies/zhang-2026-role-chronic yearly 0.4 https://www.vagusresearch.com/studies/wu-2018-treating-major yearly 0.4 https://www.vagusresearch.com/studies/makkawi-2025-efficacy-treating yearly 0.4 https://www.vagusresearch.com/studies/yan-2022-combined-rehabilitation yearly 0.4 https://www.vagusresearch.com/studies/wei-2023-efficacy-safety yearly 0.4 https://www.vagusresearch.com/studies/premaratne-2025-neurostimulation-drug yearly 0.4 https://www.vagusresearch.com/studies/han-2025-pharmaceutical-modulations yearly 0.4 https://www.vagusresearch.com/studies/ahmed-2022-adjunct-electric yearly 0.4 https://www.vagusresearch.com/studies/zhang-2022-cognitive-function yearly 0.4 https://www.vagusresearch.com/studies/xia-2025-transauricular-postoperative yearly 0.4 https://www.vagusresearch.com/studies/pan-2025-perioperative-autonomic yearly 0.4 https://www.vagusresearch.com/studies/chapman-2021-reduce-ileus yearly 0.4 https://www.vagusresearch.com/studies/perin-2025-potential-modulate yearly 0.4 https://www.vagusresearch.com/studies/paccione-2022-meditative-diaphragmatic yearly 0.4 https://www.vagusresearch.com/studies/akkurt-2025-left-bilateral yearly 0.4 https://www.vagusresearch.com/studies/neves-2026-laterality-dependent yearly 0.4 https://www.vagusresearch.com/studies/leon-ariza-2022-somatosensory-evoked yearly 0.4 https://www.vagusresearch.com/studies/zhang-2022-neuroprotective-mechanisms yearly 0.4 https://www.vagusresearch.com/studies/korupolu-2024-neurorehabilitation yearly 0.4 https://www.vagusresearch.com/studies/young-2020-brain-modalities yearly 0.4 https://www.vagusresearch.com/studies/chen-2024-therapy-dravet yearly 0.4 https://www.vagusresearch.com/studies/tseng-2022-assessment-brain yearly 0.4 https://www.vagusresearch.com/studies/cui-2025-efficacy-safety yearly 0.4 https://www.vagusresearch.com/studies/hasan-2015-treatment-schizophrenia yearly 0.4 https://www.vagusresearch.com/studies/osoegawa-2018-brain-negative yearly 0.4 https://www.vagusresearch.com/studies/dong-2023-disorders-consciousness yearly 0.4 https://www.vagusresearch.com/studies/zhou-2023-efficacy-safety yearly 0.4 https://www.vagusresearch.com/studies/gao-2025-neuromodulation-disorders yearly 0.4 https://www.vagusresearch.com/studies/contreras-2023-optimizing-systemic yearly 0.4 https://www.vagusresearch.com/studies/camargo-2024-evidence-bottom yearly 0.4 https://www.vagusresearch.com/studies/kim-2026-potential-application yearly 0.4 https://www.vagusresearch.com/studies/yang-2023-complementary-alternative yearly 0.4 https://www.vagusresearch.com/studies/shi-2024-effective-treatment yearly 0.4 https://www.vagusresearch.com/studies/zuo-2025-efficacy-safety yearly 0.4 https://www.vagusresearch.com/studies/ru-2023-low-intensity yearly 0.4 https://www.vagusresearch.com/studies/cal-2024-single-session yearly 0.4 https://www.vagusresearch.com/studies/di-flumeri-2025-potential-treatment yearly 0.4 https://www.vagusresearch.com/studies/hua-2025-inflammatory-parameters yearly 0.4 https://www.vagusresearch.com/studies/souza-2026-neuromodulation-heart yearly 0.4 https://www.vagusresearch.com/studies/ackland-2025-exercise-capacity yearly 0.4 https://www.vagusresearch.com/studies/hatik-2023-cycling-ergometry yearly 0.4 https://www.vagusresearch.com/studies/shahmandi-2026-percutaneous-fatigue yearly 0.4 https://www.vagusresearch.com/studies/balan-2026-post-covid yearly 0.4 https://www.vagusresearch.com/studies/natelson-2021-possible-treatment yearly 0.4 https://www.vagusresearch.com/studies/tarn-2023-fatigue-participants yearly 0.4 https://www.vagusresearch.com/studies/borges-2020-may-enhance yearly 0.4 https://www.vagusresearch.com/studies/jost-2026-may-improve yearly 0.4 https://www.vagusresearch.com/studies/yi-2026-postoperative-pain yearly 0.4 https://www.vagusresearch.com/studies/salama-2020-attenuates-acute yearly 0.4 https://www.vagusresearch.com/studies/shi-2026-reduces-postoperative yearly 0.4 https://www.vagusresearch.com/studies/berry-2013-patient-level yearly 0.4 https://www.vagusresearch.com/studies/aaronson-2013-therapy-different yearly 0.4 https://www.vagusresearch.com/studies/martin-2012-treatment-depression yearly 0.4 https://www.vagusresearch.com/studies/daban-2008-safety-efficacy yearly 0.4 https://www.vagusresearch.com/studies/lv-2019-depression yearly 0.4 https://www.vagusresearch.com/studies/rosson-2026-long-term yearly 0.4 https://www.vagusresearch.com/studies/vagus-nerve-stimulation-study-group-1995-chronic-treatment yearly 0.4 https://www.vagusresearch.com/studies/degiorgio-2005-epilepsy-comparison yearly 0.4 https://www.vagusresearch.com/studies/klinkenberg-2012-children-intractable yearly 0.4 https://www.vagusresearch.com/studies/morris-2013-evidence-guideline yearly 0.4 https://www.vagusresearch.com/studies/ryvlin-2014-long-term yearly 0.4 https://www.vagusresearch.com/studies/bauer-2016-treatment-drug yearly 0.4 https://www.vagusresearch.com/studies/englot-2016-rates-predictors yearly 0.4 https://www.vagusresearch.com/studies/li-2026-improves-functional yearly 0.4 https://www.vagusresearch.com/studies/kox-2015-transvenous-does yearly 0.4 https://www.vagusresearch.com/studies/li-2022-efficacy-safety yearly 0.4 https://www.vagusresearch.com/studies/hays-2026-closed-loop yearly 0.4 https://www.vagusresearch.com/studies/wang-2026-effectiveness-stroke yearly 0.4 https://www.vagusresearch.com/studies/sharma-2023-stimulator-associated yearly 0.4 https://www.vagusresearch.com/studies/wittbrodt-2020-decreases-brain yearly 0.4 https://www.vagusresearch.com/studies/debnath-2026-posttraumatic-stress yearly 0.4 https://www.vagusresearch.com/studies/benzouak-2025-treatment-trauma yearly 0.4 https://www.vagusresearch.com/studies/burger-2016-conditioned-fear yearly 0.4 https://www.vagusresearch.com/studies/burger-2017-mixed-evidence yearly 0.4 https://www.vagusresearch.com/studies/burger-2018-extinction-prepared yearly 0.4 https://www.vagusresearch.com/studies/burger-2019-fear-generalization yearly 0.4 https://www.vagusresearch.com/studies/szeska-2020-promoting-long yearly 0.4 https://www.vagusresearch.com/studies/dagostini-2025-does-not yearly 0.4 https://www.vagusresearch.com/studies/szeska-2025-ready-translation yearly 0.4 https://www.vagusresearch.com/studies/konstam-2026-heart-failure yearly 0.4 https://www.vagusresearch.com/studies/santanna-2021-neuromodulation-chronic yearly 0.4 https://www.vagusresearch.com/studies/antonino-2017-acutely-improves yearly 0.4 https://www.vagusresearch.com/studies/wolf-2021-does-affect yearly 0.4 https://www.vagusresearch.com/studies/mbikyo-2024-low-level yearly 0.4 https://www.vagusresearch.com/studies/nagai-2025-association-between yearly 0.4 https://www.vagusresearch.com/studies/wang-2025-tragus-attenuates yearly 0.4 https://www.vagusresearch.com/studies/tan-2025-cardiovascular-function yearly 0.4 https://www.vagusresearch.com/studies/chapman-2024-reduce-ileus yearly 0.4 https://www.vagusresearch.com/studies/cui-2026-pectoral-intercostal yearly 0.4 https://www.vagusresearch.com/studies/hasani-2025-sleep-quality yearly 0.4 https://www.vagusresearch.com/studies/sarr-2012-empower-prospective yearly 0.4 https://www.vagusresearch.com/studies/ikramuddin-2014-reversible-intermittent yearly 0.4 https://www.vagusresearch.com/studies/shikora-2015-sustained-weight yearly 0.4 https://www.vagusresearch.com/studies/morton-2016-blockade-moderate yearly 0.4 https://www.vagusresearch.com/studies/fadel-2023-therapy-management yearly 0.4 https://www.vagusresearch.com/studies/straube-2015-treatment-chronic yearly 0.4 https://www.vagusresearch.com/studies/zhang-2026-individual-patient yearly 0.4 https://www.vagusresearch.com/studies/gaul-2016-prevention-acute yearly 0.4 https://www.vagusresearch.com/studies/gierthmuehlen-2026-against-fatigue yearly 0.4 https://www.vagusresearch.com/studies/cibulcova-2024-influence-week yearly 0.4 https://www.vagusresearch.com/studies/ravestein-2025-does-not yearly 0.4 https://www.vagusresearch.com/studies/ridgewell-2021-cognition-healthy yearly 0.4 https://www.vagusresearch.com/studies/zhao-2023-improves-working yearly 0.4 https://www.vagusresearch.com/studies/fischer-2018-enhances-conflict yearly 0.4 https://www.vagusresearch.com/studies/miyatsu-2024-enhances-second yearly 0.4 https://www.vagusresearch.com/studies/austelle-2024-attenuates-early yearly 0.4 https://www.vagusresearch.com/studies/pacheco-barrios-2024-transauricular-enhances yearly 0.4 https://www.vagusresearch.com/studies/buchman-2026-pain-severity yearly 0.4 https://www.vagusresearch.com/studies/wang-2026-electroencephalography-microstates yearly 0.4 https://www.vagusresearch.com/studies/wang-2026-home-improves yearly 0.4 https://www.vagusresearch.com/studies/van-midden-2024-100-parkinson yearly 0.4 https://www.vagusresearch.com/studies/sigurdsson-2025-feasibility-safety yearly 0.4 https://www.vagusresearch.com/studies/abouelmagd-2025-effectiveness-parkinson yearly 0.4 https://www.vagusresearch.com/studies/xiang-2026-improvement-cognitive yearly 0.4 https://www.vagusresearch.com/studies/sanchez-perez-2023-median-reduce yearly 0.4 https://www.vagusresearch.com/studies/mcintire-2021-ctvns-improves yearly 0.4 https://www.vagusresearch.com/studies/bottenheft-2025-ctvns-military yearly 0.4 https://www.vagusresearch.com/studies/drost-2025-physiological-responses yearly 0.4 https://www.vagusresearch.com/studies/dos-reis-2024-multisession-prefrontal yearly 0.4 https://www.vagusresearch.com/studies/capone-2015-cortical-excitability yearly 0.4 https://www.vagusresearch.com/studies/wang-2023-improved-motor yearly 0.4 https://www.vagusresearch.com/studies/gerges-2025-modifies-cortical yearly 0.4 https://www.vagusresearch.com/studies/gianlorenco-2024-age-modifier yearly 0.4 https://www.vagusresearch.com/studies/gazi-2022-reduces-behavioral yearly 0.4 https://www.vagusresearch.com/studies/erturk-2026-post-exercise yearly 0.4 https://www.vagusresearch.com/studies/yoshida-2025-hemodynamics-autonomic yearly 0.4 https://www.vagusresearch.com/studies/muthulingam-2021-neuromodulation-chronic yearly 0.4 https://www.vagusresearch.com/studies/percin-2025-women-temporomandibular yearly 0.4